Purchase Order 36C26323P0416
Award Date 2/24/23
Potential Completion Date 3/6/23
Potential Value $150K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Orlando, FL 32824, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business and manufacturer, for the delivery of Emergency Patient Profounda Miltefosine Dose Packs. The $16,650 contract has an April 30, 2024 completion date and supports the VHA's mission to provide healthcare services to veterans by ensuring access to this specialty pharmaceutical product. Profounda has previously received...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer. The $116,550 contract is for the delivery of Miltefosine, a medication used to treat leishmaniasis and other drug-resistant infections in veterans. The contract has an ultimate completion date of September 30, 2024 and is part of a larger $1,127,000 Blanket Purchase Agreement (BPA)...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network (VISN) 20, to Profounda Inc. for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections. The contract, valued at $16,650.00, does not have a set-aside designation and is intended to support the VA's mission of providing healthcare services to veterans by ensuring rapid access to...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $16,750 purchase order to Profounda Inc. for the delivery of 50mg miltefosine capsules. The firm fixed price contract runs from December 14, 2023 through January 13, 2024 and will be performed in Omaha, Nebraska. Profounda Inc. will provide the pharmaceutical products to VA-VHA under this contract to support their healthcare services for veterans. No subcontractors or set aside...
- This is a firm fixed-price purchase order award to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products, for the delivery of Impavido/Miltefosine capsules and tablets. The award, valued at $99,900.00, was made by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs (VA). Profounda Inc. specializes in producing and distributing this critical medication used to treat leishmaniasis and...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 23 to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The $49,950.00 contract is for the delivery of the emergency medication miltefosine (Impavido) to the Minneapolis VA Medical Center. Profounda Inc. has a significant Blanket Purchase Agreement (BPA) with VISN 8 to provide miltefosine on a...
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The $144,000.00 firm fixed-price purchase order is for the delivery of Impavido/Miltefosine, a specialized medication used to treat leishmaniasis and other drug-resistant infections in veterans. Profounda Inc. has received numerous similar purchase orders from various Veterans Integrated...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business. The $49,950.00 contract is for the delivery of Profounda's Impavido/Miltefosine pharmaceutical product to the VA Sunshine Healthcare Network (VISN 20) in Orlando, Florida. Impavido/Miltefosine is used to treat leishmaniasis and other drug-resistant infections in veterans. This award is the latest in a...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $96,000.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections, with a focus on providing emergency pharmaceutical solutions to veterans. Profounda Inc. has a...
- Profounda Inc. was awarded a $50,050 purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 to provide emergency medication Impavidio/Miltefosine for the Minneapolis VA Medical Center. The firm fixed price contract runs from October 5, 2023 through October 19, 2023 and will be performed by Profounda Inc.'s Orlando, Florida division. No subcontractors or set aside designations were identified. The award supports the Veterans...